URL copied Image Source : PTI
Earlier this month, the committee had highlighted the possibility that the second dose of mRNA vaccines may be associated with a small risk of myocarditis and pericarditis in young men.
The benefits of receiving an mRNA coronavirus vaccine continue to outweigh the risks of getting inoculated, the Singapore government s expert committee on COVID-19 vaccination said in response to an open letter by a group of doctors, according to a media report.
Earlier this month, the committee had highlighted the possibility that the second dose of mRNA vaccines may be associated with a small risk of myocarditis and pericarditis in young men, Channel News Asia reported on Monday.
The benefits of receiving an mRNA coronavirus vaccine continue to outweigh the risks of getting inoculated, the Singapore government s expert committee on COVID-19 vaccination said in response to an open letter by a group of doctors, according to a media report. Earlier this month, the committee had highlighted the possibility that the second dose of mRNA vaccines may be associated with a small risk of myocarditis and pericarditis in young men, Channel News Asia reported on Monday. Myocarditis and pericarditis are inflammatory conditions that affect the heart muscles and the outer lining of the heart respectively. The assessment after our review is that the benefits of receiving the mRNA COVID-19 vaccines continue to outweigh the risks of vaccination, said the committee. Data on myocarditis and pericarditis has not changed since, and the Expert Committee s assessment remains the same.
Covid-19: Experts urge caution over govt plan to ease restrictions when two-thirds of Singapore are fully vaccinated | Singapore malaymail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from malaymail.com Daily Mail and Mail on Sunday newspapers.
Caris Precision Oncology Alliance Continues to Grow Internationally as it Welcomes Curie Oncology from Singapore
Curie Oncology expands Caris collaborative network of oncology institutions focused on research into personalized therapies through precision medicine
News provided by
Share this article
IRVING, Texas, March 9, 2021 /PRNewswire/
Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced today that Curie Oncology from Singapore has joined Caris Precision Oncology Alliance™ (POA). The POA is a collaborative network of leading cancer centers that work together to advance comprehensive cancer profiling and establish standards of care for molecular testing in oncology through research focused on predictive and prognostic markers that improve clinical outcomes of cancer patients.
Clinic nurse on trial for of molesting male patient twice at Mt Elizabeth Novena theindependent.sg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theindependent.sg Daily Mail and Mail on Sunday newspapers.